Mantegazza R - Search Results

1

Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.

Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Nowak RJ, Andersen H, Casasnovas C, de Bleecker JL, Vu TH, Mantegazza R, O'Brien FL, Wang JJ, Fujita KP, Howard JF Jr; Regain Study Group. Muppidi S, et al. Among authors: mantegazza r. Muscle Nerve. 2019 Jul;60(1):14-24. doi: 10.1002/mus.26447. Epub 2019 Mar 8. Muscle Nerve. 2019. PMID: 30767274 Free PMC article.

2

A short plasma exchange protocol is effective in severe myasthenia gravis.

Antozzi C, Gemma M, Regi B, Berta E, Confalonieri P, Peluchetti D, Mantegazza R, Baggi F, Marconi M, Fiacchino F, et al. Antozzi C, et al. Among authors: mantegazza r. J Neurol. 1991 Apr;238(2):103-7. doi: 10.1007/BF00315690. J Neurol. 1991. PMID: 1856735

3

Prospects for specific immunotherapy in myasthenia gravis.

Steinman L, Mantegazza R. Steinman L, et al. Among authors: mantegazza r. FASEB J. 1990 Jul;4(10):2726-31. doi: 10.1096/fasebj.4.10.2197152. FASEB J. 1990. PMID: 2197152 Review.

4

A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy.

Mantegazza R, Beghi E, Pareyson D, Antozzi C, Peluchetti D, Sghirlanzoni A, Cosi V, Lombardi M, Piccolo G, Tonali P, et al. Mantegazza R, et al. J Neurol. 1990 Oct;237(6):339-44. doi: 10.1007/BF00315656. J Neurol. 1990. PMID: 2277266 Clinical Trial.

5

Chloroquine myopathy and myasthenia-like syndrome.

Sghirlanzoni A, Mantegazza R, Mora M, Pareyson D, Cornelio F. Sghirlanzoni A, et al. Among authors: mantegazza r. Muscle Nerve. 1988 Feb;11(2):114-9. doi: 10.1002/mus.880110205. Muscle Nerve. 1988. PMID: 3343986

6

Detection of antibody classes and subpopulations in myasthenia gravis patients using a new nonradioactive enzyme immunoassay.

Gotti C, Balestra B, Mantegazza R, Tzartos S, Moretti M, Clementi F. Gotti C, et al. Among authors: mantegazza r. Muscle Nerve. 1997 Jul;20(7):800-8. doi: 10.1002/(sici)1097-4598(199707)20:7<800::aid-mus3>3.0.co;2-b. Muscle Nerve. 1997. PMID: 9179151

7

The MG Composite: A valid and reliable outcome measure for myasthenia gravis.

Burns TM, Conaway M, Sanders DB; MG Composite and MG-QOL15 Study Group. Burns TM, et al. Neurology. 2010 May 4;74(18):1434-40. doi: 10.1212/WNL.0b013e3181dc1b1e. Neurology. 2010. PMID: 20439845 Free PMC article.

8

Treatment of myasthenia gravis: focus on pyridostigmine.

Maggi L, Mantegazza R. Maggi L, et al. Among authors: mantegazza r. Clin Drug Investig. 2011 Oct 1;31(10):691-701. doi: 10.2165/11593300-000000000-00000. Clin Drug Investig. 2011. PMID: 21815707 Review.

9

The thymus in myasthenia gravis: Site of "innate autoimmunity"?

Cavalcante P, Le Panse R, Berrih-Aknin S, Maggi L, Antozzi C, Baggi F, Bernasconi P, Mantegazza R. Cavalcante P, et al. Among authors: mantegazza r. Muscle Nerve. 2011 Oct;44(4):467-84. doi: 10.1002/mus.22103. Muscle Nerve. 2011. PMID: 21922466

10

Recommendations for myasthenia gravis clinical trials.

Benatar M, Sanders DB, Burns TM, Cutter GR, Guptill JT, Baggi F, Kaminski HJ, Mantegazza R, Meriggioli MN, Quan J, Wolfe GI; Task Force on MG Study Design of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Benatar M, et al. Among authors: mantegazza r. Muscle Nerve. 2012 Jun;45(6):909-17. doi: 10.1002/mus.23330. Muscle Nerve. 2012. PMID: 22581550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

333 results

Search Page